Detalhe da pesquisa
1.
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer.
Nature
; 529(7586): 413-417, 2016 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26735014
2.
Why do BCL-2 inhibitors work and where should we use them in the clinic?
Cell Death Differ
; 25(1): 56-64, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29077093
3.
Inhibition of MAPKinase pathway sensitizes thyroid cancer cells to ABT-737 induced apoptosis.
Cancer Lett
; 395: 1-10, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28259821
4.
Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical Outcomes.
Cancer Res
; 76(22): 6495-6506, 2016 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27671678
5.
Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.
Cancer Res
; 75(20): 4384-4397, 2015 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26249174